Chao Chen

Regeneron Pharmaceuticals, Inc.

Poster(s):

• (B-184) Equity in Pharmacoepidemiology: Improving Understanding of Use, Benefits, and Risks of Medicinal Products in Human Populations
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (B-188) Safety and Effectiveness of Cemiplimab in Combination with Platinum-Doublet Chemotherapy by Demographic Characteristics in First-Line Treatment of Advanced Non-Small Cell Lung Cancer: An Ongoing Real World Evidence Study
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET